Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Sell
2,120
-555
-21% -$55K ﹤0.01% 1016
2026
Q1
$252K Sell
2,675
-5,791
-68% -$578K ﹤0.01% 941
2025
Q4
$836K Buy
8,466
+5,552
+191% +$537K 0.02% 565
2025
Q3
$247K Buy
+2,914
New +$230K 0.01% 866
2025
Q1
Sell
-2,900
Closed -$200K 873
2024
Q4
$200K Buy
+2,900
New +$207K 0.01% 748
2024
Q1
Sell
-3,285
Closed -$206K 731
2023
Q4
$206K Buy
+3,285
New +$186K 0.01% 631
2023
Q2
Sell
-2,864
Closed -$207K 643
2023
Q1
$207K Hold
2,864
0.01% 590
2022
Q4
$239K Sell
2,864
-86
-3% -$6.58K 0.01% 554
2022
Q3
$226K Sell
2,950
-100
-3% -$7.39K 0.01% 557
2022
Q2
$220K Hold
3,050
0.01% 520
2022
Q1
$242K Hold
3,050
0.02% 450
2021
Q4
$224K Buy
+3,050
New +$206K 0.02% 446
2021
Q3
Sell
-2,650
Closed -$223K 435
2021
Q2
$223K Sell
2,650
-100
-4% -$8.34K 0.02% 403
2021
Q1
$223K Buy
2,750
+5
+0.2% +$427 0.02% 403
2020
Q4
$258K Sell
2,745
-35
-1% -$3.03K 0.03% 371
2020
Q3
$249K Hold
2,780
0.03% 352
2020
Q2
$289K Hold
2,780
0.04% 301
2020
Q1
$204K Buy
+2,780
New +$210K 0.04% 320

Other funds holding INCY

RFG Advisory's INCY Position: Q2 2026 in Review

RFG Advisory reduced its Incyte (INCY) stake by 21% in Q2 2026, selling an estimated $55K and leaving 2,120 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

RFG Advisory first reported a position in INCY in Q1 2020 and has held it in 18 quarters since. The position peaked at $836K in Q4 2025. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • RFG Advisory held 2,120 shares of Incyte worth $240K as of Q2 2026.
  • RFG Advisory sold 555 Incyte shares in Q2 2026, an estimated $55K.
  • Incyte made up ﹤0.01% of RFG Advisory's portfolio in Q2 2026, its #1016 holding.
  • RFG Advisory first reported a position in Incyte in Q1 2020 and has held it in 18 quarters since.
  • RFG Advisory's Incyte position peaked at $836K in Q4 2025.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.